Table 2. Comparison of Baseline and End of Study Characteristics in Treatment and Control Groups a.
| Variable | Control Group | Treatment Group | ||||
|---|---|---|---|---|---|---|
| Baseline | End of Study | P Value | Baseline | End of Study | P Value | |
| IL-6, pg/mL | 4 | 4.3 | NS | 5.13 | 3.96 | 0.01 |
| Hb, mg/dL | 9.9 | 10.65 | 0.016 | 10.1 | 10.9 | 0.007 |
| WBC, /µL | 7.18 × 103 | 7.15 × 103 | 0.3 | 8.6 × 103 | 6.7 × 103 | 0.003 |
| CRP, mg/L | 9.3 | 10.3 | NS | 10.47 | 7.8 | 0.04 |
| SGOT, IU/L | 22.6 | 19.7 | NS | 18.6 | 20.4 | NS |
| LDH, IU/L | 304 | 254 | NS | 186 | 205 | NS |
| CPK, IU/L | 61.3 | 80 | NS | 56.8 | 70 | NS |
a Abbreviations: NS, non-significant; WBC, white blood cell, LDH, Lactate dehyrogenase; CPK, reatine phosphokinase; SGOT, Serum glutamic oxaloacetic transaminase; CRP, C-reactive protein.